Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
SID & GP summarized the work carried out over the past year
The results of the work by the GMP-inspectorate became the main topic of the meeting with representatives of the top Russian mass media held by the Director of the FSI 'SID&GP'.
EAEU’s pharma regulatory landscape was discussed at the VI All-Russia Congress
Participants of the VI All-Russia Congress "Pharmaceutical activities in Russia and the EAEU" discussed the regulatory framework of pharmaceutical activities in Russia and within the EAEU.
SID&GP to held a workshop on GMP requirements for API manufacturing
On 20-21 December, the State Institute of Drugs and Good Practices (FSI "SID&GP") jointly with Pharmstrategy Ltd. will held an open expert-advisory workshop "Requirements and Application of GMP Ru...
Indian pharma manufacturers had a meeting with Russian colleagues
The event was initiated by the Council for promoting the development of export by Indian pharma manufacturers with support from the Ministry of Commerce and Industry of the Government of India.
Pharma market penetration of Russian drugs rose in the 1st half of 2018
Russian drugs penetration into the pharmaceutical market rose in the 1st half of 2018. This was presented to the participants of "Pharma CFO 2018" by Raziya Solodova.
‘SID & GP’ experts attended the VI international forum “Anti-counterfeit 2018...
The representatives of the State Institute of Drugs and Good Practices of Minpromtorg of Russia took part in the International Forum «Anti-counterfeit 2018» in Moscow (Russia).
Data integrity was discussed at the ‘Pharmtech & Ingredients’ exhibition
On 20 November, at the exhibition "Pharmtech & Ingredients", held in Crocus Expo (Moscow), the panel discussion on the topic "Data integrity management: key aspects" was organized.
‘RegLek-2018’ conference participants discussed issues in drug evaluation
On 19th November the scientific-practical conference 'RegLek-2018', was held in Moscow. Participants of the event discussed the modern approaches to drugs expert evaluation.
St. Petersburg hosts 8th annual forum “Life Sciences Invest. Partnering Russia”
The VIII annual international partnering-forum "Life Sciences Invest. Partnering Russia" started in St. Petersburg. The first day of the Forum brought together nearly 650 people. The key discussion...
SID&GP signs a cooperation agreement with PharmaPharm
The State Institute of Drugs and Good Practices signed a cooperation agreement with the integrated pharmaceutical portal PharmaPharm within the framework of Life Sciences Invest in St. Petersburg.
SID&GP representatives participated in workshop on pharma industry automation
Representatives of the State Institute of Drugs and Good Practices took part in the workshop dedicated to automation of the pharmaceutical industry organized by the Ministry of Industry and Trade.
Representatives of ‘SID&GP’ visited the opening of Nearmedic workshop
On 31 October, at the manufacturing site of the Nearmedic Pharma company in Kaluga region, a new workshop for reagents used in genetic identity evidence and propinquity establishment was opened.
FSI ‘SID&GP’ starts the community of experts ‘PharmaPharm’
The community of experts has been started at FSI "SID & GP" of Minpromtorg of Russia, which provides invaluable expert support throughout the whole period of web-site development.
The Director of FSI ‘SID & GP’ participated in the XI Eurasian Economic Forum
The Director of the Russian Federal State-funded Institution “State Institute of Drugs and Good Practices”, Vladislav Shestakov, took part in the XI Eurasian Economic Forum.
FSI ‘SID&GP’ held a meeting with GE Healthcare Life Sciences
On 24 October, the representatives of the FSI "SID&GP" held a business meeting with foreign and Russian colleagues from the GE Healthcare Life Sciences company.
SID&GP discussed Russian legislation harmonization with EAEU law
The Director of FSI "SID&GP" took part in the round-table discussion on the topic "The issues of Russian legislation harmonization with EAEU law".
Page 2 of 4
Pharmasyntez Group of Companies
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
API Ropivacaine Hydrochloride
for production of sterile dosage forms registered in Russia
pharmaceutical salt is exclusively made of highly purified vacuum salt
PHARMASAL API complies with
• Ph. EUR, BP, US, JP, RU
• Prequalified Active Pharmaceutical Ingredients
PHARMASAL HD complies with
• Ph. EUR, BP, US, JP, RU
A product of Salinen Austria AG
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
EAEU may allow to register empty primary packages as medical...
Inspection of Foreign Manufacturers of Veterinary Products
FDA Approved XCOPRI to Treat Partial-Onset Seizures
BioCity UK Life Science Start-Up Report Reveals ‘Baby Boom’ ...
Subscribe to Newsletter!
© GMP news